Literature DB >> 25944771

Usefulness of procalcitonin and C-reactive protein for predicting bacteremia in urinary tract infections in the emergency department.

A Julián-Jiménez1, P Gutiérrez-Martín2, A Lizcano-Lizcano3, M A López-Guerrero4, Á Barroso-Manso2, E Heredero-Gálvez5.   

Abstract

INTRODUCTION: The aim of this study was to analyze and compare the capacity of procalcitonin (PCT), C-reactive protein (CRP), lactate and leukocytes to predict the presence of bacteremia in patients with urinary tract infections (UTIs).
METHODS: Observational, retro-prospective analytical study of adult patients (≥15 years) diagnosed with UTI in an emergency department from August 2012 to January 2013.
RESULTS: The study included 328 patients diagnosed with UTI, with a mean age of 52±22 years, 74% of whom were women. Of these, 43 (13.1%) had bacteremia. For predicting bacteremia, PCT achieved the largest area under the receiver operating characteristic curve (ROC-AUC) at .993 (95% CI .987-1; P<.001). A cutoff≥1.16ng/mL achieves a sensitivity of 100%, a specificity of 97%, a positive predictive value of 84% and a negative predictive value of 100%. Lactate achieved an ROC-AUC of .844, and CRP achieved only .534. The mean values when comparing PCT levels in patients with UTIs with and without bacteremia were 8.08±16.37 and .34±.37ng/mL, respectively (P<.001).
CONCLUSIONS: For patients with UTIs in the emergency department, PCT achieves considerable diagnostic performance for suspecting bacteremia, a performance greater than that of lactate, CRP and leukocytes.
Copyright © 2015 AEU. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Bacteremia; Bacteriemia; Biomarcadores; Biomarkers; C-reactive protein; Emergency department; Infección del tracto urinario; Procalcitonin; Procalcitonina; Proteína C reactiva; Servicio de urgencias; Urinary tract infection

Mesh:

Substances:

Year:  2015        PMID: 25944771     DOI: 10.1016/j.acuro.2015.03.003

Source DB:  PubMed          Journal:  Actas Urol Esp        ISSN: 0210-4806            Impact factor:   0.994


  7 in total

Review 1.  Procalcitonin-guided diagnosis and antibiotic stewardship revisited.

Authors:  Ramon Sager; Alexander Kutz; Beat Mueller; Philipp Schuetz
Journal:  BMC Med       Date:  2017-01-24       Impact factor: 8.775

2.  Risk factors for concomitant positive midstream urine culture in patients presenting with symptomatic ureterolithiasis.

Authors:  Nico C Grossmann; Victor M Schuettfort; Christian D Fankhauser; Benedikt Kranzbühler; Jeannine Betschart; Anton S Becker; Thomas Hermanns; Etienne X Keller
Journal:  Urolithiasis       Date:  2022-04-20       Impact factor: 3.436

3.  The Presence of Bacteremia Indicates Higher Inflammatory Response and Augments Disease Severity in Adult Patients with Urinary Tract Infections.

Authors:  Chien-Chin Hsu; Pei-Chen Lin; Kuo-Tai Chen
Journal:  J Clin Med       Date:  2022-07-21       Impact factor: 4.964

Review 4.  [New predictive models of bacteremia in the emergency department: a step forward].

Authors:  A Julián-Jiménez; R Rubio-Díaz; J González Del Castillo; F J Candel
Journal:  Rev Esp Quimioter       Date:  2022-04-13       Impact factor: 2.515

5.  Diagnostic value of serum procalcitonin, lactate, and high-sensitivity C-reactive protein for predicting bacteremia in adult patients in the emergency department.

Authors:  Chiung-Tsung Lin; Jang-Jih Lu; Yu-Ching Chen; Victor C Kok; Jorng-Tzong Horng
Journal:  PeerJ       Date:  2017-11-27       Impact factor: 2.984

6.  Serum procalcitonin as a biomarker of bloodstream infection & focal bacterial infection in febrile patients.

Authors:  Janjam Harikrishna; Alladi Mohan; D P Kalyana Chakravarthi; Abhijit Chaudhury; B Siddhartha Kumar; K V S Sarma
Journal:  Indian J Med Res       Date:  2020-04       Impact factor: 2.375

7.  Utilization of serum procalcitonin as a biomarker in the diagnosis and treatment of children with bacterial hospital-acquired pneumonia.

Authors:  Wenlong Wang; Yitang Zhu; Linlin Yin; Yaoyao Deng; Guoxian Chu; Supin Liu
Journal:  Mol Cell Biochem       Date:  2020-09-29       Impact factor: 3.396

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.